Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum β-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 1, 2003, Pages 36-42

  Melano, Roberto ^a   Corso, Alejandra ^a   Petroni, Alejandro ^a   Cetrón, Daniela ^b   Orman, Betina ^b   Pereyra, Adriana ^c   Moreno, Noemí ^c   Galas, Marcelo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^c Hospital 'Gobernador Centeno'   (Argentina)

Author keywords

CTX M 2; In35; PER 2; Tn1331; Tn3

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIBUTEN; CEFTRIAXONE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; FURAZOLIDONE; GENTAMICIN; IMIPENEM; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TAZOBACTAM; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CHILDHOOD DISEASE; CHRONIC DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; HUMAN; IN VIVO STUDY; INFANT; INTEGRON; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PLASMID; PROTEIN ANALYSIS; URINARY TRACT INFECTION;

ARGENTINA; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CONJUGATION, GENETIC; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; INFANT; ISOELECTRIC FOCUSING; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0038262694     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Babini, G. S. & Livermore, D. M. (2000). Are SHV beta-lactamases universal in Klebsiella pneumoniae? Antimicrobial Agents and Chemotherapy 44, 2230.
2. Du Bois, S., Marriott, M. & Amyes, S. (1995). TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. Journal of Antimicrobial Chemotherapy 35, 7-22.
3. Jacoby, G. A. & Medeiros, A. A. (1991). More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 35, 1697-1704.
4. Galas, M., Rapoport, M., Pasterán, F. et al. (1999). High distribution of CTX-M-2 β-lactamase among Klebsiella spp. isolates in an Argentinean extended spectrum β-lactamase (ESBLA) surveillance program. In Program and Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 1474, p. 165. American Society for Microbiology, Washington, DC, USA.
5. Bradford, P. A., Cherubin, C. E., Idemyor, V. et al. (1994). Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrobial Agents and Chemotherapy 38, 761-6.
6. Essack, S., Hall, L., Pillay, D. et al. (2001). Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrobial Agents and Chemotherapy 45, 88-95.
7. Liu, P., Tung, J. C., Ke, S. C. et al. (1998). Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. Journal of Clinical Microbiology 36, 2759-62.
8. Pai, H., Lyu, S., Lee, J. et al. (1999). Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. Journal of Clinical Microbiology 37, 1758-63.
9. Kim, J., Kwon, Y., Pai, H. et al. (1998). Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. Journal of Clinical Microbiology 36, 1446-9.
10. Soilleux, M., Morand, A., Arlet, G. et al. (1996). Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrobial Agents and Chemotherapy 40, 1027-9.
11. Yuan, M., Hall, L., Hoogkamp-Korstanje, J. et al. (2001). SHV-14, a novel β-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands. Antimicrobial Agents and Chemotherapy 45, 309-11.
12. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
13. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing - Twelfth Informational Supplement: MIC Testing, M100-S12. NCCLS, Wayne, PA, USA.
14. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Disk Susceptibility Test - Seventh Edition: Approved Standard M2-A7. NCCLS, Wayne, PA, USA.
15. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing - Twelfth Informational Supplement: Disk Diffusion M100-S12. NCCLS, Wayne, PA, USA.
16. Petroni, A., Corso, A., Melano, R. et al. (2002). Plasmidic extended-spectrum β-lactamases in Vibrio cholerae O1 El Tor in Argentina. Antimicrobial Agents and Chemotherapy 46, 1462-8.
17. Labia, R. & Barthélémy, M. (1979). L'enzymogramme des beta-lactamases: adaptation en cel de la methode iodometrique. Annales de Microbiologie (Paris) 130B, 295-304.
18. Masuda, G., Tomioka, S. & Hasegawa, M. (1976). Detection of β-lactamase production by gram-negative bacteria. Journal of Antibiotics (Tokyo) 29, 662-4.
19. Martínez-Martínez, L., Hernández-Allés, S., Abertí, S. et al. (1996). In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 40, 342-8.
20. Foodborne and Diarrheal Diseases Branch, Centers for Disease Control and Prevention. (1998). Standarized Molecular Subtyping of Foodborne Bacterial Pathogens by Pulsed-Field Gel Electrophoresis: A Training Manual. Centers for Disease Control and Prevention, Atlanta, GA, USA.
21. Nakamura, M., Sato, S., Ohya, T. et al. (1986). Plasmid profile analysis in epidemiological studies of animal Salmonella typhimurium infection in Japan. Journal of Clinical Microbiology 23, 360-5.
22. Levesque, C., Piche, L., Larose, C. et al. (1995). PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrobial Agents and Chemotherapy 39, 185-91.
23. Arlet, G. & Philippon, A. (1989). Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB). FEMS Microbiology Letters 82, 19-26.
24. Sanger, S., Micklen, S. & Coulson, A. (1977). DNA sequencing with chain-terminating inhibitors. Procedings of the National Academy of Sciences, USA 74, 5463-7.
25. Tenover, F. C., Arbeit, R. D., Goering, R. V. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
26. González-Leiza, M., Pérez-Díaz, J., Ayala, J. et al. (1994). Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrobial Agents and Chemotherapy 38, 2150-7.
27. Papanicolau, G. A., Medeiros, A. A. & Jacoby, G. A. (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 34, 2200-9.
28. Ardanuy, C., Liñares, J., Domínguez, M. et al. (1998). Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrobial Agents and Chemotherapy 42, 1636-40.
29. Martínez-Martínez, L., Pascual, A., Hernández-Allés, S. et al. (1999). Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 43, 1669-73.
30. CTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrobial Agents and Chemotherapy 46, 2303-6.
31. CTX-M-2 in Salmonella enterica serovar Infantis. Antimicrobial Agents and Chemotherapy 46, 2257-61.
32. Tolmasky, M. & Crosa, J. (1993). Genetic organization of antibiotic resistance genes (aac(6′)-Ib, aadA, and oxa9) in the multiresistance transposon Tn 1331. Plasmid 29, 31-40,
33. Galas, M. F., Pasterán, F. G., Melano, R. G. et al. (1998). Unusual distribution of enzymatic resistance to third-generation cephalosporin (TGC) in E. coli in Argentina. In Program and Abstracts of the Thirty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract E-109, p. 201. American Society for Microbiology, Washington, DC, USA.
34. Pasterán, F. G., Melano, R. G., Galas, M. F. et al. (1999). High proportion of extended spectrum β-lactamases (ESBLA) among AmpC producers enterobacteria in Argentina. In Program and Abstracts of the Thirty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 1475, p. 166. American Society for Microbiology, Washington, DC, USA.